451.61MMarket Cap
LossP/E TTM
AVTX Balance Sheet
You can check out the annual or quarterly balance sheets of Avalo Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing AVTX stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Avalo Therapeutics Inc Have?
In its most recent quarterly, Avalo Therapeutics Inc had 24.99M in cash and cash equivalents.
What Are Avalo Therapeutics Inc's Total Assets?
As of the latest reported quarter, Avalo Therapeutics Inc's total assets were 116.46M, consisting of 105.29M in current assets and 11.17M in non-current assets.
How Much Shareholders' Equity Does Avalo Therapeutics Inc Have?
Avalo Therapeutics Inc reported 83.05M in total shareholders' equity as of the latest reported quarter.